Boér, K.; Kaposi, A.; Kocsis, J.; Horváth, Z.; Madaras, B.; Sávolt, Á.; Klément, G.B.; Rubovszky, G.
How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer. Cancers 2024, 16, 2928.
https://doi.org/10.3390/cancers16172928
AMA Style
Boér K, Kaposi A, Kocsis J, Horváth Z, Madaras B, Sávolt Á, Klément GB, Rubovszky G.
How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer. Cancers. 2024; 16(17):2928.
https://doi.org/10.3390/cancers16172928
Chicago/Turabian Style
Boér, Katalin, Ambrus Kaposi, Judit Kocsis, Zsolt Horváth, Balázs Madaras, Ákos Sávolt, Gyorgy Benjamin Klément, and Gábor Rubovszky.
2024. "How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer" Cancers 16, no. 17: 2928.
https://doi.org/10.3390/cancers16172928
APA Style
Boér, K., Kaposi, A., Kocsis, J., Horváth, Z., Madaras, B., Sávolt, Á., Klément, G. B., & Rubovszky, G.
(2024). How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer. Cancers, 16(17), 2928.
https://doi.org/10.3390/cancers16172928